Cargando…
Impaired Fetal Environment and Gestational Age: What Is Driving Mortality in Neonates With Critical Congenital Heart Disease?
BACKGROUND: Infants with critical congenital heart disease (CCHD) are more likely to be small for gestational age (SGA) or born to mothers with maternal placental syndrome. The objective of this study was to investigate the relationship between maternal placental syndrome, SGA, and gestational age (...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6915289/ https://www.ncbi.nlm.nih.gov/pubmed/31726960 http://dx.doi.org/10.1161/JAHA.119.013194 |
_version_ | 1783479981484015616 |
---|---|
author | Steurer, Martina A. Peyvandi, Shabnam Baer, Rebecca J. Oltman, Scott P. Chambers, Christina D. Norton, Mary E. Ryckman, Kelli K. Moon‐Grady, Anita J. Keller, Roberta L. Shiboski, Stephen C. Jelliffe‐Pawlowski, Laura L. |
author_facet | Steurer, Martina A. Peyvandi, Shabnam Baer, Rebecca J. Oltman, Scott P. Chambers, Christina D. Norton, Mary E. Ryckman, Kelli K. Moon‐Grady, Anita J. Keller, Roberta L. Shiboski, Stephen C. Jelliffe‐Pawlowski, Laura L. |
author_sort | Steurer, Martina A. |
collection | PubMed |
description | BACKGROUND: Infants with critical congenital heart disease (CCHD) are more likely to be small for gestational age (SGA) or born to mothers with maternal placental syndrome. The objective of this study was to investigate the relationship between maternal placental syndrome, SGA, and gestational age (GA) on 1‐year mortality in infants with CCHD. METHODS AND RESULTS: In a population‐based administrative database of all live‐born infants in California (2007–2012) we identified all infants with CCHD without chromosomal anomalies. Our primary predictor was an impaired fetal environment (IFE), defined as presence of maternal placental syndrome or SGA. We calculated hazard ratios to quantify the association between different components of IFE and 1‐year mortality and conducted a causal mediation analysis to assess GA at birth as a mediator. We identified 6863 infants with CCHD. IFE was present in 25.1%. Infants with IFE were more likely to die than infants without IFE (16.6% versus 11.1%; hazard ratios 1.55, 95% CI 1.34–1.78). Only SGA (hazard ratios 1.76, 95% CI 1.50–2.05) and placental abruption (hazard ratios 1.70, 95% CI 1.17–2.48) were significantly associated with mortality; preeclampsia and gestational hypertension had no significant association with mortality. The mediation analysis showed that 32.8% (95% CI 24.9–47.0%) of the relationship between IFE and mortality is mediated through GA. CONCLUSIONS: IFE is a significant contributor to outcomes in the CCHD population. SGA and placental abruption are the main drivers of postnatal mortality while other maternal placental syndrome components had much less of an impact. Only one third of the effect between IFE and mortality is mediated through GA. |
format | Online Article Text |
id | pubmed-6915289 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-69152892019-12-23 Impaired Fetal Environment and Gestational Age: What Is Driving Mortality in Neonates With Critical Congenital Heart Disease? Steurer, Martina A. Peyvandi, Shabnam Baer, Rebecca J. Oltman, Scott P. Chambers, Christina D. Norton, Mary E. Ryckman, Kelli K. Moon‐Grady, Anita J. Keller, Roberta L. Shiboski, Stephen C. Jelliffe‐Pawlowski, Laura L. J Am Heart Assoc Original Research BACKGROUND: Infants with critical congenital heart disease (CCHD) are more likely to be small for gestational age (SGA) or born to mothers with maternal placental syndrome. The objective of this study was to investigate the relationship between maternal placental syndrome, SGA, and gestational age (GA) on 1‐year mortality in infants with CCHD. METHODS AND RESULTS: In a population‐based administrative database of all live‐born infants in California (2007–2012) we identified all infants with CCHD without chromosomal anomalies. Our primary predictor was an impaired fetal environment (IFE), defined as presence of maternal placental syndrome or SGA. We calculated hazard ratios to quantify the association between different components of IFE and 1‐year mortality and conducted a causal mediation analysis to assess GA at birth as a mediator. We identified 6863 infants with CCHD. IFE was present in 25.1%. Infants with IFE were more likely to die than infants without IFE (16.6% versus 11.1%; hazard ratios 1.55, 95% CI 1.34–1.78). Only SGA (hazard ratios 1.76, 95% CI 1.50–2.05) and placental abruption (hazard ratios 1.70, 95% CI 1.17–2.48) were significantly associated with mortality; preeclampsia and gestational hypertension had no significant association with mortality. The mediation analysis showed that 32.8% (95% CI 24.9–47.0%) of the relationship between IFE and mortality is mediated through GA. CONCLUSIONS: IFE is a significant contributor to outcomes in the CCHD population. SGA and placental abruption are the main drivers of postnatal mortality while other maternal placental syndrome components had much less of an impact. Only one third of the effect between IFE and mortality is mediated through GA. John Wiley and Sons Inc. 2019-11-15 /pmc/articles/PMC6915289/ /pubmed/31726960 http://dx.doi.org/10.1161/JAHA.119.013194 Text en © 2019 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Original Research Steurer, Martina A. Peyvandi, Shabnam Baer, Rebecca J. Oltman, Scott P. Chambers, Christina D. Norton, Mary E. Ryckman, Kelli K. Moon‐Grady, Anita J. Keller, Roberta L. Shiboski, Stephen C. Jelliffe‐Pawlowski, Laura L. Impaired Fetal Environment and Gestational Age: What Is Driving Mortality in Neonates With Critical Congenital Heart Disease? |
title | Impaired Fetal Environment and Gestational Age: What Is Driving Mortality in Neonates With Critical Congenital Heart Disease? |
title_full | Impaired Fetal Environment and Gestational Age: What Is Driving Mortality in Neonates With Critical Congenital Heart Disease? |
title_fullStr | Impaired Fetal Environment and Gestational Age: What Is Driving Mortality in Neonates With Critical Congenital Heart Disease? |
title_full_unstemmed | Impaired Fetal Environment and Gestational Age: What Is Driving Mortality in Neonates With Critical Congenital Heart Disease? |
title_short | Impaired Fetal Environment and Gestational Age: What Is Driving Mortality in Neonates With Critical Congenital Heart Disease? |
title_sort | impaired fetal environment and gestational age: what is driving mortality in neonates with critical congenital heart disease? |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6915289/ https://www.ncbi.nlm.nih.gov/pubmed/31726960 http://dx.doi.org/10.1161/JAHA.119.013194 |
work_keys_str_mv | AT steurermartinaa impairedfetalenvironmentandgestationalagewhatisdrivingmortalityinneonateswithcriticalcongenitalheartdisease AT peyvandishabnam impairedfetalenvironmentandgestationalagewhatisdrivingmortalityinneonateswithcriticalcongenitalheartdisease AT baerrebeccaj impairedfetalenvironmentandgestationalagewhatisdrivingmortalityinneonateswithcriticalcongenitalheartdisease AT oltmanscottp impairedfetalenvironmentandgestationalagewhatisdrivingmortalityinneonateswithcriticalcongenitalheartdisease AT chamberschristinad impairedfetalenvironmentandgestationalagewhatisdrivingmortalityinneonateswithcriticalcongenitalheartdisease AT nortonmarye impairedfetalenvironmentandgestationalagewhatisdrivingmortalityinneonateswithcriticalcongenitalheartdisease AT ryckmankellik impairedfetalenvironmentandgestationalagewhatisdrivingmortalityinneonateswithcriticalcongenitalheartdisease AT moongradyanitaj impairedfetalenvironmentandgestationalagewhatisdrivingmortalityinneonateswithcriticalcongenitalheartdisease AT kellerrobertal impairedfetalenvironmentandgestationalagewhatisdrivingmortalityinneonateswithcriticalcongenitalheartdisease AT shiboskistephenc impairedfetalenvironmentandgestationalagewhatisdrivingmortalityinneonateswithcriticalcongenitalheartdisease AT jelliffepawlowskilaural impairedfetalenvironmentandgestationalagewhatisdrivingmortalityinneonateswithcriticalcongenitalheartdisease |